Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
piclamilast phosphodiesterase 4a NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Rheumatoid Arthritis[MeSHID:D001172]
1.37 phase 2 unknown
piclamilast camp-specific 3',5'-cyclic phosphodiesterase 4a small molecule NA drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Rheumatoid Arthritis[MeSHID:D001172]
1.37 experimental unknown
piclamilast phosphodiesterase 4b NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Rheumatoid Arthritis[MeSHID:D001172]
1.93 phase 2 unknown
piclamilast camp-specific 3',5'-cyclic phosphodiesterase 4b small molecule NA drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Rheumatoid Arthritis[MeSHID:D001172]
1.93 experimental unknown
piclamilast camp-specific 3',5'-cyclic phosphodiesterase 4c small molecule NA drugbank Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Rheumatoid Arthritis[MeSHID:D001172]
NA experimental unknown
piclamilast camp-specific 3',5'-cyclic phosphodiesterase 4d small molecule NA drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Rheumatoid Arthritis[MeSHID:D001172]
2.12 experimental unknown
piclamilast phosphodiesterase 4d NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Rheumatoid Arthritis[MeSHID:D001172]
2.12 phase 2 unknown
click here to return to the previous page